Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy
暂无分享,去创建一个
J. Jaremko | S. Israels | S. Atkinson | F. Rauch | S. Kaste | S. Abish | D. Cabral | J. Ho | K. Siminoski | C. Fernandez | K. Koujok | N. Alos | J. Halton | P. Miettunen | L. Ward | E. Cummings | C. Rodd | R. Stein | M. Matzinger | P. Babyn | N. Shenouda | Beverly A. Wilson | D. Dix | M. Scharke | Jinhui Ma | V. Lewis | R. Barr | Elizabeth Cairney | R. Grant | A. Sbrocchi
[1] C. Morris,et al. Bisphosphonate Therapy for Treating Osteonecrosis in Pediatric Leukemia Patients: A Systematic Review. , 2020, Journal of pediatric hematology/oncology.
[2] M. Relling,et al. Incidence of hip and knee osteonecrosis and their associations with bone mineral density in children with acute lymphoblastic leukaemia , 2020, British journal of haematology.
[3] Pio Zeppa,et al. Non-Hodgkin Lymphoma. , 2020, Monographs in clinical cytology.
[4] A. Borkhardt,et al. Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy , 2019, Leukemia & lymphoma.
[5] J. Jaremko,et al. Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six‐Year Prospective Cohort Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] B. Zemel,et al. Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia. , 2018, Bone.
[7] J. Harbott,et al. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. , 2016, Blood.
[8] D. Little,et al. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL) , 2016, Cancer medicine.
[9] J. Downing,et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J. Jaremko,et al. Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis. , 2015, The Journal of clinical endocrinology and metabolism.
[11] R. Pieters,et al. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia , 2015, Haematologica.
[12] J. Downing,et al. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] W. Hop,et al. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. , 2014, Bone.
[14] P. Auquier,et al. Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood , 2013, Haematologica.
[15] A. Nettel-Aguirre,et al. Widespread Osteonecrosis in Children With Leukemia Revealed by Whole-body MRI , 2012, Clinical orthopaedics and related research.
[16] H. Sather,et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. , 2012, The Lancet. Oncology.
[17] S. Taback,et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] F. Rauch,et al. The dynamics of bone structure development during pubertal growth. , 2012, Journal of musculoskeletal & neuronal interactions.
[19] W. Hop,et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] T. Hangartner,et al. Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. , 2011, The Journal of clinical endocrinology and metabolism.
[21] D. Peck. Slipped capital femoral epiphysis: diagnosis and management. , 2010, American family physician.
[22] S. Kaste,et al. How Does Osteonecrosis About the Knee Progress in Young Patients with Leukemia?: A 2- to 7-year Study , 2010, Clinical orthopaedics and related research.
[23] D. Moher,et al. Advanced Vertebral Fracture Among Newly Diagnosed Children With Acute Lymphoblastic Leukemia: Results of the Canadian Steroid‐Associated Osteoporosis in the Pediatric Population (STOPP) Research Program , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] R. Pieters,et al. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia , 2008, Haematologica.
[25] M. Relling,et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. , 2008, Blood.
[26] R. Barr,et al. Osteonecrosis in children and adolescents with cancer , 2008, Pediatric blood & cancer.
[27] E. Pääkkö,et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] C. Pui,et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] R. Barr,et al. Osteonecrosis in children and adolescents with cancer - an adverse effect of systemic therapy. , 2007, European journal of cancer.
[30] P. Lafforgue. Pathophysiology and natural history of avascular necrosis of bone. , 2006, Joint, bone, spine : revue du rhumatisme.
[31] S. Rai,et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 1, observer agreement. , 2006, AJR. American journal of roentgenology.
[32] S. Richards,et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial , 2005, British journal of haematology.
[33] M. Schrappe,et al. Osteonecrosis: A treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)—experiences from trial ALL‐BFM 95 , 2005, Pediatric blood & cancer.
[34] Tjeerd P van Staa,et al. Epidemiology of Childhood Fractures in Britain: A Study Using the General Practice Research Database , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] T. Kubo,et al. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head , 2002, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[36] E. Krenning,et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. , 2002, The Journal of pediatrics.
[37] M. Levien. Osteonecrosis as a Complication of Treating Acute Lymphoblastic Leukemia in Children: A Report From the Children's Cancer Group , 2002, Clinical pediatrics.
[38] R. Gelber,et al. Bony morbidity in children treated for acute lymphoblastic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] C. Pui,et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma , 2001, Leukemia.
[40] H. Sather,et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] A. Parfitt,et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. , 1998, The Journal of clinical investigation.
[42] S. Atkinson,et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] C. Rosen,et al. Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. , 1989, Journal of the American Dietetic Association.
[45] M. Reed,et al. Orthopaedic manifestations of leukemia in children. , 1986, The Journal of bone and joint surgery. American volume.
[46] M. Kransdorf,et al. From the Radiologic Pathology Archives 1 Imaging of Osteonecrosis : Radiologic-Pathologic Correlation 2 , 2014 .
[47] M. Relling,et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. , 2010, Blood.
[48] M. Relling,et al. A PAI-1 ( SERPINE 1 ) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia : a report from the Children ’ s Oncology Group , 2008 .
[49] H. Pan,et al. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age , 2006 .
[50] A. Colevas,et al. The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 is the new standard for oncology clinical trials. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] Lester R Curtin,et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. , 2002, Pediatrics.
[52] E. Pääkkö,et al. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. , 1999, Medical and pediatric oncology.
[53] its Panel on Folate,et al. STANDING COMMITTEE ON THE SCIENTIFIC EVALUATION OF DIETARY REFERENCE INTAKES , 1998 .
[54] C. Pui,et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.